Kaitlin Kestenberg
Compliance Officer at ADMA BIOLOGICS, INC.
Net worth: 2 M $ as of 30/04/2024
Network origin in Kaitlin Kestenberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 30 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kaitlin Kestenberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MARKER THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Advion BioSciences, Inc.
 Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Chairman | |
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member | |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman | |
| ATON | Pharmaceuticals: Major | Director/Board Member | |
Oculex Pharmaceuticals, Inc.
 Oculex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oculex Pharmaceuticals, Inc. manufactures and develops drugs. The company focuses on developing and manufacturing novel drug delivery systems that resolve the problems associated with treatment of inflammation following cataract surgery and diseases of the eye. It is located in Sunnyvale, CA. | Pharmaceuticals: Major | Chairman | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
Medical Knowledge Group LLC
 Medical Knowledge Group LLC Pharmaceuticals: MajorHealth Technology Medical Knowledge Group LLC engages in the provision of medical communications and health care services. It offers medical communications, health care consulting, and data analytics. The company was founded by Edward Lazarowitz, Leon Behar and Jeffrey K. Schab in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
ADMA Plasma Biologics, Inc.
 ADMA Plasma Biologics, Inc. BiotechnologyHealth Technology ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer | |
Genesis BPS LLC
 Genesis BPS LLC Medical/Nursing ServicesHealth Services Genesis BPS LLC engages in collection, processing, storage and preparation of blood and biological fluids. Its products include GENESIS RapidWeld, TCD sterilr tube welder, blood collection monitor and data collection mixer. The company was founded by Jerrold B. Grossman and is headquartered in Ramsey, NJ. | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
National Hospital Specialties
 National Hospital Specialties Medical DistributorsDistribution Services National Hospital Specialties sells biologics, plasma, and pharmaceuticals. The private company is based in Hackensack, NJ. The company was founded by Jerrold B. Grossman, who has been the CEO since incorporation. | Medical Distributors | Chief Executive Officer Corporate Officer/Principal | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| JHL BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ajax Health LLC
 Ajax Health LLC Investment ManagersFinance Ajax Health LLC (Ajax Health) is a private Equity and venture capital firm founded in 2017 by Duke S. Rohlen. The firm is headquartered in Menlo Park, California. | Investment Managers | Director/Board Member | |
FinHealth Gestão de Recursos SA
 FinHealth Gestão de Recursos SA Investment ManagersFinance FinHealth Gestão de Recursos SA (FinHealth) an independent private equity and venture capital firm headquartered in Rio de Janeiro, Brazil. It was founded in 2010. | Investment Managers | Private Equity Investor | |
Marker Cell Therapy, Inc.
 Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Marker Cell Therapy, Inc. develops clinical stage immuno-oncology therapies. The company is headquartered in New Brighton, MN. | Miscellaneous Commercial Services | Director/Board Member | |
Ajax Health II LLC
 Ajax Health II LLC Investment ManagersFinance Ajax Health II LLC invests in companies located in the United States. The fund target companies operating in the fields of innovative medical device companies. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Director/Board Member | |
| NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Chairman | |
| GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 35 |
| Germany | 10 |
| France | 3 |
| Denmark | 2 |
| Cayman Islands | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 5 |
Operational
| Director/Board Member | 124 |
| Corporate Officer/Principal | 42 |
| Independent Dir/Board Member | 32 |
| Undergraduate Degree | 31 |
| President | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Steven Elms | 37 |
| Arnold Kling | 30 |
| Dov Goldstein | 28 |
| Bryant Fong | 23 |
| Eric Richman | 21 |
| Bernhard R. M. Ehmer | 16 |
| Jerrold Grossman | 15 |
| Martha Demski | 13 |
| Alison Finger | 11 |
| Lawrence Guiheen | 10 |
| Brian Lenz | 10 |
| Adam Grossman | 9 |
| Young Kwon | 8 |
| Marc S. Gelberg | 7 |
| Jeffrey Gruenglas | 5 |
- Stock Market
- Insiders
- Kaitlin Kestenberg
- Company connections
